Bone morphogenetic protein-3 (BMP3; osteogenin) is a member of the transforming growth factor-6 superfamily.
Introduction
There is accumulating evidence that TGFP superfamily members are important regulators of morphogenetic events during vertebrate embryogenesis. A subgroup of related bone morphogenetic factors (BMPs) has been discovered, including BMP-3 (osteogenin), BMP-2, BMPs 4-6, and BMP-7 (also called osteogenic protein-1; OP-1) (2, 8, 13, 20, 29) . Recombinantly expressed BMPs singly initiate cartilage and bone formation in vivo (2, 8, 19, 20, 29) . In sections of developing rat embryo, maximal binding of iodinated osteogenin was observed in mesodermal tissues such as cartilage, bone, perichondrium, and periosteum (28) . Osteogenin stimulated alkaline phosphatase activity and collagen synthesis in cultures of rat periosteal cells and in calvarial osteoblasts (26) . Rat bone marrow stromal cell cultures also enhanced formation of alkaline phosphatase-positive colonies in the presence of osteogenin (26) . Promotion of the osteogenic phenotype was confirmed in experiments with MC3T3-El osteoblastic cells; osteogenin inhibited growth and stimulated alkaline phosphatase activity within 72 hr (27) , whereas approximately 12 days are needed for their spontaneous differentiation in vitro (7) . A profound stimulation of proteoglycan synthesis in fetal rat chondroblasts and in rabbit and bovine articular chondrocytes (9, 26) 
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chick limb bud cell cultures (I), demonstrated the role of osteogenin in the promotion and maintenance of the chondrogenic phenotype.
Recently, localization studies suggested that BMP-214 (lo), Vgr-1 (BMP-6) (11), and OP-1 (BMP-7) (6,25) have other roles, distinct from bone induction, in human and mouse development. In the present study, the BMP-3 mRNA sizes and the spatial and temporal distribution of the mRNA and protein were analyzed during human development. We found that BMP-3, although isolated from bone matrix, is produced by other tissues and may regulate morphogenesis and/or function of human lung, kidney, and intestine.
Materials and Methods
Human Tissue. The 57 human embryos and fetuses ranging from 5-14 weeks of gestation [lo-52 mm crown-rump length (CRL)] used in the present study were obtained from legal abortions at the University of Zagreb Medical School. The gestational age of each embryo or fetus was estimated in weeks (W) on the basis of CRL and pregnancy records of the conceptual age (12) . The procedure for the human autopsy material was approved and controlled by the Internal Review Board of the Ethical Committee at the School of Medicine, University of Zagreb, and the Office of Human Subjects Research (OHSR) at the National Institutes of Health, Bethesda, MD. The material was fixed at 4°C in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). embedded in paraffin, and cut serially at 5 pm.
BMP3 Antibody. The polyclonal FS-3 antibody was generated in rabbits with a synthetic peptide of 19 amino acids representing the N-terminus of mature BMP-3 monomer (aa. 329-348). Antibody purification was carried out with a peptide affinity column (ProtOnTM Kit; Multiple Peptide 869 Systems. San Diego. CA). The ELlSA-tested anti-peptide antibody titer for the affinity-purified fractions was similar to that of the crude serum. The FS-3 antibody screened by Wmcm blot analysis did not m a with BMP-214. OP-1 (BMP-7). TGPsl or TGF-PZ. In the area that corresponds to the peptide antigen sequence used to produce the FS-3 antibody, there is no sequence homology with BMP-5 and BMP-6.
Immunonaining. Sections were stained as recommended by the manufacturer, using immunogold as a detection system (Auroprobe LM) Uanssen; Beem, Belgium) and were counterstained with 0.1% toluidine blue. The primary antibody was used at a dilution of I5 pglml in TBS, 0.5% BSA. for I hr. In the controls. the primary antibody was replaced with either BSA, normal rabbit serum. or secondary antibody alone.
Probe Construction. From a full-length human BMP-3 cDNA clone (a gift from William Wood, Gcnenrech. San Francisco). a 660 BP LORI-EcoRV fragment covering 60 BP of the 5' flanking region and the pro-region was selected and subcloned into a pGEM-2 vector. A shorter 210 BP fragment (obtained by digesting the 660 BP BMP-3 probe with EcoRl and Pstl) was also subcloned into a pGEM-2 vector (Promega; Madison. WI). Probes from a region other than the highly conserved 7-cysteine domain of BMP-3 were used to avoid cross-hybridization of closely related genes. This BMP-3 region has low similarity with known bone morphogenetic proteins (BMP-2 30%. BMP-4 23%. BMP-5 25%. BMP-6 27%. BMP-7 25% (GcneWorks; In-telliGcnctics. Mountain View. CA). Single-stranded sense and anti-sense RNA proba were labeled with [a-"S]-UTP (Ncw England Nuclear; Boston, MA) by in vitro-transcription using either SP6 or T7 polymerase.
In Situ Hybridisation. Sections of 5-7 vm thick were cut. mounted on silinated slides, heated at 45'C overnight. and kept at 4'C. For in situ hybridization, sections were depanffiniscd, rehydrated. and post-fixed for 20 min in 4% paraformaldehyde. Pre-treatment included incubation in 0.2 N HCI ( 5 min). proteinase K digestion (20 pglml, 10 min). additional post-fixation ( 5 min). blocking of nonspecific sulfur-binding sites with iodoacetamide (0.37 g1400 ml) and N-ethylmaleimidc (0.25 g1400 ml), acetic anhydride tmtmcnr (0.5% in 0.1 M triethanolamine-HCI, pH 8; twice for 10 min). and dehydration using a graded wries of ethanol. Limited albline hydrolysis (4) reduced the 660 BP BMP-3 probe to an average size of 150-200 BP. Sections were hybridized for 16-18 hr at 5o'C in 50% formamide. After hybridization, the sections were washed as dexribed earlier (17) . treated with RNA= A (Sigma; St Louis, MO). covered with NBT-2 emulsion (Kodak; Rochester. NY). and exposed for 1-3 weeks. After devclopment, the slides were stained with 0.1% toluidine blue.
Nonhem Hybiidiution. Total RNA from human fetal tissue of [12] [13] [14] weeks' gestation was prepared by the acid guanidine thiocyanate-phenol-chloroform method (3). The RNA was dissolved in TES buffer (10 mM Tris-HCI. 1 mM EDTA, 0.10% SDS. pH 7.5) and treated with proteinw K (1.5 mglg tissue sample) at 45'C for 1 hr. Poly(A)' RNA was isolated on oligo-dTcolumns (Strategene; LaJolla. CA). Poly(A)' RNA (2 pgllanc) was fractionated on 1% agarose-formaldehyde gels. Membranes were hybridized in Hybrizol (Oncor; (kkhcrsburg. MD) at 42'C for 48 hr. f o l l d by washing at 24% for 5 min and twice at 65'C for 15 min with PES buffer (40 mM NaHzP04, 1 mM EDTA, and 1% SDS). For re-ux. the filters were stripped in 50% formamide in 6 x SSPE at 65-8o'C for 30 min.
Results

Kssue-specz-c BMP-3 mRNA Transcripts
BMP-3 expression was analyzed in several tissues of 12-14-week human embryos by Northern hybridization. Hybridization with a probe that covers the pre-pro-region revealed two mRNA species of about 7 and 3 KB in fetal human tissues (Figure 1 pression was observed in fetal lung and kidney, whereas heart and liver did not give detectable signals. Only the higher mRNA size was detected in brain ( Figure 1 ). The highest level of BMP-3 mRNA was found in the fetal developing lungs.
BMP-3 RNA and Protein Locahzation During Human Embryonic Development
The spatial and temporal distribution of BMP-3 was analyzed further with in situ hybridization and immunohistochemistry on human embryos of6-14 weeks' gestation. At 6 weeks' gestation. BMP-3 was expressed in the epithelium lining the stem bronchus of the developing lung (Figures 2A-2C ). At 9 (Figures 3C and 3D ) and 12 ( Figure 2G ) weeks. the transcripts were also present in the epithelial cells lining the buds of bronchial branches. Positive staining of bronchial epithelium was observed with the FS-3-specific BMP-3 anubody throughout the obsemuon period (Fgurc 4). BMP-3 was also expressed in intestinal mucosa ( Figures 3E and 3F ). kidney (Figures 4 and 5B) . perichondrium. and periosteum (Figures 2D. 2E, 3A. and 3B). Strong staining for BMP-3 protein was observed in the gut epithelium between 8 and 14 weeks (Figures 3E  and 3F ) and in bone matrix between 10-14 weeks' gestation (not shown). In kidney, BMP-3 wu expressed in the epithelium ofstmight collecting tubules at both the RNA and the protein level (Figures  4 and 5) . At early developmental stages, positive staining was also observed in mesonephric tubules ( Figure 4C ).
Discussion
These localization studies demonstrated that BMP-3 (osteogenin). 1 KB (14) . The presence of multipIe mRNA transcripts for one BMP member suggests a formation of more tissueor function-specific gene products by means of altemative splicing of the precursor mRNA and/or post-translational processing. The fact that we observed only the 7 KB transcript in brain, whereas other tissues displayed two transcripts of 7 KB and 3 KB, may support t h i s assumption.
. -
The presented in situ hybridization data have confirmed lung and kidney as major sites for BMP-3 synthesis. High expression levels were demonstrated in skeletal tissues, such as periosteal bone collar, and at several extraskeletal sites. Recent in situ hybridization studies of BMP-214 suggested additional roles for BMPs during murine embryonic development. Transcripts were demonstrated in developing heart, whisker follicles, and tooth buds, in addition to the expected localization in developing limb bud (10,11,24 ). Osteogenic protein-1 (BMP-7) was, in addition to osteogenic sites, highly expressed in the kidney, urinary.bladder (15) , and heart (25) .
All the recombinantly expressed BMPs singly initiate de novo cartilage and bone formation in a rat in vivo subcutaneous assay (2,8,19,20,29) . This raises questions about the biological relevance 18.22,23) might reflect genomic compensatory mechanisms for potentially lethal damage in genes involved in skeletal development. The subcutaneous rat bioassay therefore seems functionally not specific enough, and might identify morphogenetic molecules with a different primary physiologic function. This is clearly underscored by the fact that two TGF-B superfamily members of the invertebrate Drosophila involved in pattern formation, decapentaplegic (dpp) and 60 A, have the capacity to induce ectopic endochondral bone formation in mammals (21). In the reverse situation, human BMP-4 is able to confer the normal embryonic dorsal-ventral patterning in &sophila transformants defective in expressing dpp (16) . These observations suggest that BMPs may function as morphogens and that their bone inductive capacity in mammals depends on the developmental state of the receptive tissue. Taken together, the localization studies and the reported functions of several members in development suggest that BMPs 2, 4, and 7 (OP-1) have a more widespread role, such as signaling molecules in epithelial-mesenchymal interactions in a number of tissues during early development (11,24,25) .
The present data suggest that BMP-3 may have, in addition to bone formation, other regulatory roles in the morphogenesis and/or function of human lung, kidney, and intestine.
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